Abstract
No public abstract is available from the verified source records.
Catia Simoes, Carmen Gonzalez, François Vergez, Audrey Sarry, Sarah Bertoli, Beñat Ariceta, David Martínez-Cuadrón, Juan Miguel Bergua Burgues, Lorenzo Algarra, Pilar Martinez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla, Jose-Luis Lopez-Lorenzo, Maria-Belen Vidriales, Carmen Chillon, Jorge Labrador, Jose-Francisco Falantes, María-José Sayas, Rosa Ayala, Joaquin Martinez-Lopez, Sara Villar, Maria-Jose Calasanz, Felipe Prosper, Jesús F. San-Miguel, Miguel Á. Sanz, Christian Récher, Bruno Paiva, Pau Montesinos, F. Rojas, H. Longoni, G. Milone, I. Fernández, Clínica Conciencia, R. Ramirez, C. Canepa, S. Saba, G. Balladares, C. Ventiurini, R. Mariano, P. Negri, M.V. Prates, J. Milone, P. Fazio, M. Gelemur, S. Ciarlo, F. Bezares, L. López, J. J García, M. Giunta, M. Kruss, D. Lafalse, E. Marquesoni
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
10.1182/blood-2016-08-733196 · 2017
The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms
10.1038/s41375-022-01613-1 · 2022
International Consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data
10.1182/blood.2022015850 · 2022
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
10.1182/blood.2022016867 · 2022
Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia
10.1182/blood.2020007897 · 2021
Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia
10.1038/s41408-022-00712-7 · 2022
Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity
10.1016/j.cell.2019.01.031 · 2019
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia
10.1038/s41591-022-01819-x · 2022
A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia
10.1002/cncr.33403 · 2021
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
10.1038/leu.2012.120 · 2012
The mutational landscape of acute myeloid leukaemia predicts responses and outcomes in elderly patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial
10.3390/cancers13102458 · 2021
Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types
10.1126/science.1247651 · 2014
Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses
10.1016/j.cell.2017.04.014 · 2017
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
10.1038/s41591-018-0233-1 · 2018
Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia
10.1158/2159-8290.cd-19-0710 · 2020
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features
10.1038/leu.2016.126 · 2016
Comprehensive integration of single-cell data
10.1016/j.cell.2019.05.031 · 2019
The Human Cell Atlas bone marrow single-cell interactive web portal
10.1016/j.exphem.2018.09.004 · 2018
Integrated single-cell analysis maps the continuous regulatory landscape of human hematopoietic differentiation
10.1016/j.cell.2018.03.074 · 2018
Identification of the thyrotropin-releasing hormone (TRH) as a novel biomarker in the prognosis for acute myeloid leukemia
10.3390/biom12101359 · 2022
No additional external references are available.